Posted on March 30, 2023 |
The Craneware Group (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today publicly announces it supports and underwrites the advocacy group 340B Matters. In 2016, guided by a ...
Posted on January 17, 2023 |
“The 19 drug companies that have imposed restrictions on safety-net hospital access to 340B drug pricing program discounts collectively brought more than $660 billion in revenues in 2021. The banner ...
Posted on January 12, 2023 |
“A federal court has ruled it’s up to the HHS to determine how to repay hospitals enrolled in the 340B drug discount program after years of underpayments, sparking concern from ...
Posted on January 10, 2023 |
“The House of Representatives Dec. 23 passed an amended version of the $1.7 trillion omnibus appropriations bill that funds the federal government through the end of the current fiscal year. ...
Posted on June 13, 2022 |
“Seventeen drug companies, including some of the world’s largest, are flouting a 30-year-old federal program that supports hospitals serving patients with low incomes and those who live in rural communities. ...